EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Prenatal Diagnosis and Management of Kaposiform Hemangioendothelioma With Kasabach–Merritt Phenomenon: Imaging Features and First Experience With Maternal Sirolimus Therapy

Antoine Fraissenon, Chris Minella iD, Marion Bordas-Fournel iD, Anne Gaëlle Grebille, Olivia Boccara, Marie Cassart, Sarah Simon-Locatelli iD, Gwenaelle André, Guillaume Canaud, Alexandre Guilhem, Sara Cabet, Laurent Guibaud

Prenatal Diagnosis · 2026

DOI: 10.1002/pd.70180 ↗

At a glance

Journal article in Prenatal Diagnosis, 2026. Written by Antoine Fraissenon and 11 co-authors. Institution: Centre de Référence des Anomalies Vasculaires Superficielles, Imagerie pédiatrique et fœtale, Hôpital Femme Mère Enfant, Université Claude Bernard Ly…. Major MEDLINE topics: Antibiotics, Antineoplastic, Hemangioendothelioma, Kasabach-Merritt Syndrome, Sarcoma, Kaposi. 13 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

To describe the prenatal diagnosis, evolution, and perinatal management of kaposiform hemangioendothelioma (KHE) complicated by the Kasabach–Merritt phenomenon (KMP), and to report the first documented use of maternal sirolimus therapy (MST) in this setting.

Methods

We retrospectively reviewed four fetuses with a prenatal soft‐tissue mass suspected for KHE. Imaging characteristics, fetal complications, perinatal outcomes, and postnatal hematologic data were analyzed. MST was initiated in one severe case with rapidly progressive disease and early fetal compromise.

Results

All lesions demonstrated infiltrative margins, marked hypervascularity, and T2‐hyperintense signal on MRI. Three fetuses showed prenatal signs suggestive of evolving KMP. Two pregnancies were terminated. Among the two liveborn infants, one developed early neonatal KMP requiring urgent sirolimus therapy. All lesions demonstrated infiltrative margins, marked hypervascularity, and T2‐hyperintense signal on MRI. Three fetuses showed prenatal signs suggestive of evolving KMP. Two pregnancies were terminated. Among the two liveborn infants, one developed early neonatal KMP requiring urgent sirolimus therapy. In the most recent case, a temporal association was observed between MST initiation and early reduction of tumor infiltration on follow‐up MRI. The infant was delivered at 39 weeks and responded to combined sirolimus–steroid therapy.

Conclusion

Prenatal imaging can strongly suggest KHE and identify early signs of KMP. This series provides preliminary evidence that MST may represent a promising antenatal therapeutic option in selected severe cases.

Subjects

MeSH terms (MEDLINE)

Antibiotics, AntineoplasticHemangioendotheliomaKasabach-Merritt SyndromeSarcoma, KaposiSirolimusAdultFemaleHumansInfant, NewbornPregnancyMagnetic Resonance ImagingPrenatal DiagnosisRetrospective StudiesUltrasonography, Prenatal

Author keywords

fetal MRIfetal tumorkaposiform hemangioendotheliomakasabach–merritt phenomenonmaternal sirolimus therapyprenatal ultrasoundsirolimusvascular anomalies

Substances

Antibiotics, AntineoplasticSirolimus

Authors and institutions

  • Centre de Référence des Anomalies Vasculaires Superficielles, Imagerie pédiatrique et fœtale, Hôpital Femme Mère Enfant, Université Claude Bernard Lyon 1, Villeurbanne, France.
  • INSERM U1151 « Mécanismes et stratégies thérapeutiques dans les syndromes de surcroissance et les anomalies vasculaires », Institut Necker Enfants Malades, Paris, France.
  • Service de Radiologie Mère-Enfant, Hôpital Nord, CHU Saint Etienne, Saint-Priest-en-Jarez, France.
  • Centre de Diagnostic Prénatal, Hôpitaux de Strasbourg, Strasbourg, France.
  • Centre de Diagnostic Prénatal, Hôpital de Saint Brieux, Saint-Brieuc, France.
  • Dermatologie Pédiatrique, Hôpital Necker, Paris, France.

ORCID profiles: Chris Minella, Marion Bordas-Fournel, Sarah Simon-Locatelli

Cite

APA

Fraissenon, A., Minella, C., Bordas-Fournel, M., Grebille, A. G., Boccara, O., Cassart, M., Simon-Locatelli, S., André, G., Canaud, G., Guilhem, A., Cabet, S., & Guibaud, L. (2026). Prenatal Diagnosis and Management of Kaposiform Hemangioendothelioma With Kasabach–Merritt Phenomenon: Imaging Features and First Experience With Maternal Sirolimus Therapy. Prenatal Diagnosis. https://doi.org/10.1002/pd.70180

Vancouver

Fraissenon A, Minella C, Bordas-Fournel M, Grebille AG, Boccara O, Cassart M, et al. Prenatal Diagnosis and Management of Kaposiform Hemangioendothelioma With Kasabach–Merritt Phenomenon: Imaging Features and First Experience With Maternal Sirolimus Therapy. Prenatal Diagnosis. 2026. doi:10.1002/pd.70180

BibTeX
@article{Fraissenon2026,
  author = {Fraissenon, Antoine and Minella, Chris and Bordas-Fournel, Marion and Grebille, Anne Gaëlle and Boccara, Olivia and Cassart, Marie and Simon-Locatelli, Sarah and André, Gwenaelle and Canaud, Guillaume and Guilhem, Alexandre and Cabet, Sara and Guibaud, Laurent},
  title = {Prenatal Diagnosis and Management of Kaposiform Hemangioendothelioma With Kasabach–Merritt Phenomenon: Imaging Features and First Experience With Maternal Sirolimus Therapy},
  journal = {Prenatal Diagnosis},
  year = {2026},
  doi = {10.1002/pd.70180}
}
Start for free →